BLASTS 30 PERCENT OR LESS OF BONE MARROW NUCLEATED CELLS

Clinical trials for BLASTS 30 PERCENT OR LESS OF BONE MARROW NUCLEATED CELLS explained in plain language.

Never miss a new study

Get alerted when new BLASTS 30 PERCENT OR LESS OF BONE MARROW NUCLEATED CELLS trials appear

Sign up with your email to follow new studies for BLASTS 30 PERCENT OR LESS OF BONE MARROW NUCLEATED CELLS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Early trial tests Four-Drug combo to train immune system against blood cancers

Disease control Completed

This early-stage study tested a combination of a cancer vaccine, chemotherapy, and immunotherapy in 8 patients with certain high-risk blood cancers. The main goal was to check the safety of this four-drug approach and see if it could help the body's immune system better target an…

Matched conditions: BLASTS 30 PERCENT OR LESS OF BONE MARROW NUCLEATED CELLS

Phase: PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control

Last updated Mar 23, 2026 15:29 UTC

BLASTS 30 PERCENT OR LESS OF BONE MARROW NUCLEATED CELLS

Get alerted when new BLASTS 30 PERCENT OR LESS OF BONE MARROW NUCLEATED CELLS trials appear

Early trial tests Four-Drug combo to train immune system against blood cancers